Pharmaceuticals & health care

Johnson & Johnson

A global health care company focused on pharmaceuticals and medical technology.

Ticker: JNJNYSE-listedHealth care
Market chart

Johnson & Johnson stock chart

Change the time range to compare recent moves with longer trends. Chart data is provided by TradingView.

What is Johnson & Johnson?

Johnson & Johnson operates in two main segments: innovative medicine (pharmaceuticals) and medical technology (devices used in surgery, orthopedics and other clinical settings). The company separated its former consumer health division into an independent company, Kenvue, in 2023.

Why investors watch Johnson & Johnson

Johnson & Johnson is often viewed as a defensive, dividend-paying holding, with one of the longer records of consecutive annual dividend increases among large US companies. Investors watch its drug pipeline, patent timelines and device segment growth as key drivers of results.

Risks and volatility

Pharmaceutical companies face patent expirations that can affect a drug's revenue once generic competition enters, along with regulatory approval risk for new products. Johnson & Johnson has also faced product-liability litigation over the years, a general risk for large health care and consumer-product companies.

Long-term investing considerations

A long dividend-growth history is not a guarantee that it will continue. When modeling dividend income, test more conservative growth assumptions alongside the company's historical pattern.

Company snapshot

Company profile

A quick reference snapshot — sector, description and key stats, provided by TradingView.

Fundamentals

Key financials

Revenue, margins and other reported financial data, provided by TradingView. Figures reflect company filings and can change as new reports are released.